Search Reports
Categories
Categories

Global Gene Knockdown Market

Global Gene Knockdown Market Research Report 2025(Status and Outlook)

Report Code : SER9232
Published Date : 17 July, 1905 | No of Pages: 122

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Gene knockdown refers to the experimental technique used to reduce the expression of a specific gene, typically through RNA interference (RNAi), antisense oligonucleotides, or CRISPR-based methods, to study gene function or develop therapeutic interventions. This approach is widely applied in academic research, drug discovery, and biotechnology, enabling scientists to investigate gene roles in disease pathways, validate drug targets, and develop RNA-based therapies. The market for gene knockdown technologies is driven by increasing investments in genomics research, the growing prevalence of genetic disorders, and rising demand for personalized medicine. Key players include biotechnology firms, pharmaceutical companies, and academic institutions, with innovations in delivery systems, such as lipid nanoparticles and viral vectors, enhancing efficiency and specificity. However, challenges like off-target effects, delivery limitations, and regulatory hurdles may restrain growth. The market is segmented by technology (siRNA, shRNA, CRISPR), application (oncology, neurology, infectious diseases), and end-user (pharma, biotech, CROs), with North America and Europe leading due to strong R&D infrastructure, while Asia-Pacific shows rapid growth fueled by expanding biotech sectors and government funding. Competitive dynamics revolve around intellectual property, strategic collaborations, and advancements in precision gene-editing tools.

This report offers a comprehensive and in-depth analysis of the global Gene Knockdown market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Gene Knockdown market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Knockdown market.
Global Gene Knockdown Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Santa Cruz Biotechnology (US)
OriGene (US)
Sigma-Aldrich (US)
Abnova (Taiwan)
Agilent Technologies (US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals (US)
EMD Millipore (US)
BioVision (US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen (US)
Qiagen (Germany)

Market Segmentation (by Type)
siRNA
shRNA
Other

Market Segmentation (by Application)
Medical
Bioengineering
Other

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Knockdown Market
Overview of the regional outlook of the Gene Knockdown Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Knockdown Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Gene Knockdown, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Gene Knockdown
      1.2 Key Market Segments
            1.2.1 Gene Knockdown Segment by Type
            1.2.2 Gene Knockdown Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Gene Knockdown Market Overview
      2.1 Global Market Overview
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Gene Knockdown Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Gene Knockdown Product Life Cycle
      3.3 Global Gene Knockdown Revenue Market Share by Company (2020-2025)
      3.4 Gene Knockdown Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.5 Gene Knockdown Company Headquarters, Area Served, Product Type
      3.6 Gene Knockdown Market Competitive Situation and Trends
            3.6.1 Gene Knockdown Market Concentration Rate
            3.6.2 Global 5 and 10 Largest Gene Knockdown Players Market Share by Revenue
            3.6.3 Mergers & Acquisitions, Expansion
  4 Gene Knockdown Value Chain Analysis
      4.1 Gene Knockdown Value Chain Analysis
      4.2 Midstream Market Analysis
      4.3 Downstream Customer Analysis
  5 The Development and Dynamics of Gene Knockdown Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Gene Knockdown Market Porter's Five Forces Analysis
  6 Gene Knockdown Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Gene Knockdown Market Size Market Share by Type (2020-2025)
      6.3 Global Gene Knockdown Market Size Growth Rate by Type (2021-2025)
  7 Gene Knockdown Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Gene Knockdown Market Size (M USD) by Application (2020-2025)
      7.3 Global Gene Knockdown Sales Growth Rate by Application (2020-2025)
  8 Gene Knockdown Market Segmentation by Region
      8.1 Global Gene Knockdown Market Size by Region
            8.1.1 Global Gene Knockdown Market Size by Region
            8.1.2 Global Gene Knockdown Market Size Market Share by Region
      8.2 North America
            8.2.1 North America Gene Knockdown Market Size by Country
            8.2.2 U.S.
            8.2.3 Canada
            8.2.4 Mexico
      8.3 Europe
            8.3.1 Europe Gene Knockdown Market Size by Country
            8.3.2 Germany
            8.3.3 France
            8.3.4 U.K.
            8.3.5 Italy
            8.3.6 Spain
      8.4 Asia Pacific
            8.4.1 Asia Pacific Gene Knockdown Market Size by Region
            8.4.2 China
            8.4.3 Japan
            8.4.4 South Korea
            8.4.5 India
            8.4.6 Southeast Asia
      8.5 South America
            8.5.1 South America Gene Knockdown Market Size by Country
            8.5.2 Brazil
            8.5.3 Argentina
            8.5.4 Columbia
      8.6 Middle East and Africa
            8.6.1 Middle East and Africa Gene Knockdown Market Size by Region
            8.6.2 Saudi Arabia
            8.6.3 UAE
            8.6.4 Egypt
            8.6.5 Nigeria
            8.6.6 South Africa
  9 Key Companies Profile
      9.1 Santa Cruz Biotechnology (US)
            9.1.1 Santa Cruz Biotechnology (US) Basic Information
            9.1.2 Santa Cruz Biotechnology (US) Gene Knockdown Product Overview
            9.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Product Market Performance
            9.1.4 Santa Cruz Biotechnology (US) SWOT Analysis
            9.1.5 Santa Cruz Biotechnology (US) Business Overview
            9.1.6 Santa Cruz Biotechnology (US) Recent Developments
      9.2 OriGene (US)
            9.2.1 OriGene (US) Basic Information
            9.2.2 OriGene (US) Gene Knockdown Product Overview
            9.2.3 OriGene (US) Gene Knockdown Product Market Performance
            9.2.4 OriGene (US) SWOT Analysis
            9.2.5 OriGene (US) Business Overview
            9.2.6 OriGene (US) Recent Developments
      9.3 Sigma-Aldrich (US)
            9.3.1 Sigma-Aldrich (US) Basic Information
            9.3.2 Sigma-Aldrich (US) Gene Knockdown Product Overview
            9.3.3 Sigma-Aldrich (US) Gene Knockdown Product Market Performance
            9.3.4 Sigma-Aldrich (US) SWOT Analysis
            9.3.5 Sigma-Aldrich (US) Business Overview
            9.3.6 Sigma-Aldrich (US) Recent Developments
      9.4 Abnova (Taiwan)
            9.4.1 Abnova (Taiwan) Basic Information
            9.4.2 Abnova (Taiwan) Gene Knockdown Product Overview
            9.4.3 Abnova (Taiwan) Gene Knockdown Product Market Performance
            9.4.4 Abnova (Taiwan) Business Overview
            9.4.5 Abnova (Taiwan) Recent Developments
      9.5 Agilent Technologies (US)
            9.5.1 Agilent Technologies (US) Basic Information
            9.5.2 Agilent Technologies (US) Gene Knockdown Product Overview
            9.5.3 Agilent Technologies (US) Gene Knockdown Product Market Performance
            9.5.4 Agilent Technologies (US) Business Overview
            9.5.5 Agilent Technologies (US) Recent Developments
      9.6 Bio-Rad (US)
            9.6.1 Bio-Rad (US) Basic Information
            9.6.2 Bio-Rad (US) Gene Knockdown Product Overview
            9.6.3 Bio-Rad (US) Gene Knockdown Product Market Performance
            9.6.4 Bio-Rad (US) Business Overview
            9.6.5 Bio-Rad (US) Recent Developments
      9.7 Cell Signaling Technology (US)
            9.7.1 Cell Signaling Technology (US) Basic Information
            9.7.2 Cell Signaling Technology (US) Gene Knockdown Product Overview
            9.7.3 Cell Signaling Technology (US) Gene Knockdown Product Market Performance
            9.7.4 Cell Signaling Technology (US) Business Overview
            9.7.5 Cell Signaling Technology (US) Recent Developments
      9.8 GeneCopoeia (US)
            9.8.1 GeneCopoeia (US) Basic Information
            9.8.2 GeneCopoeia (US) Gene Knockdown Product Overview
            9.8.3 GeneCopoeia (US) Gene Knockdown Product Market Performance
            9.8.4 GeneCopoeia (US) Business Overview
            9.8.5 GeneCopoeia (US) Recent Developments
      9.9 siTOOLs Biotech (Germany)
            9.9.1 siTOOLs Biotech (Germany) Basic Information
            9.9.2 siTOOLs Biotech (Germany) Gene Knockdown Product Overview
            9.9.3 siTOOLs Biotech (Germany) Gene Knockdown Product Market Performance
            9.9.4 siTOOLs Biotech (Germany) Business Overview
            9.9.5 siTOOLs Biotech (Germany) Recent Developments
      9.10 Novus Biologicals (US)
            9.10.1 Novus Biologicals (US) Basic Information
            9.10.2 Novus Biologicals (US) Gene Knockdown Product Overview
            9.10.3 Novus Biologicals (US) Gene Knockdown Product Market Performance
            9.10.4 Novus Biologicals (US) Business Overview
            9.10.5 Novus Biologicals (US) Recent Developments
      9.11 EMD Millipore (US)
            9.11.1 EMD Millipore (US) Basic Information
            9.11.2 EMD Millipore (US) Gene Knockdown Product Overview
            9.11.3 EMD Millipore (US) Gene Knockdown Product Market Performance
            9.11.4 EMD Millipore (US) Business Overview
            9.11.5 EMD Millipore (US) Recent Developments
      9.12 BioVision (US)
            9.12.1 BioVision (US) Basic Information
            9.12.2 BioVision (US) Gene Knockdown Product Overview
            9.12.3 BioVision (US) Gene Knockdown Product Market Performance
            9.12.4 BioVision (US) Business Overview
            9.12.5 BioVision (US) Recent Developments
      9.13 Creative Biomart (US)
            9.13.1 Creative Biomart (US) Basic Information
            9.13.2 Creative Biomart (US) Gene Knockdown Product Overview
            9.13.3 Creative Biomart (US) Gene Knockdown Product Market Performance
            9.13.4 Creative Biomart (US) Business Overview
            9.13.5 Creative Biomart (US) Recent Developments
      9.14 Selleck Chemicals (US)
            9.14.1 Selleck Chemicals (US) Basic Information
            9.14.2 Selleck Chemicals (US) Gene Knockdown Product Overview
            9.14.3 Selleck Chemicals (US) Gene Knockdown Product Market Performance
            9.14.4 Selleck Chemicals (US) Business Overview
            9.14.5 Selleck Chemicals (US) Recent Developments
      9.15 MyBioSource (US)
            9.15.1 MyBioSource (US) Basic Information
            9.15.2 MyBioSource (US) Gene Knockdown Product Overview
            9.15.3 MyBioSource (US) Gene Knockdown Product Market Performance
            9.15.4 MyBioSource (US) Business Overview
            9.15.5 MyBioSource (US) Recent Developments
      9.16 Invitrogen (US)
            9.16.1 Invitrogen (US) Basic Information
            9.16.2 Invitrogen (US) Gene Knockdown Product Overview
            9.16.3 Invitrogen (US) Gene Knockdown Product Market Performance
            9.16.4 Invitrogen (US) Business Overview
            9.16.5 Invitrogen (US) Recent Developments
      9.17 Qiagen (Germany)
            9.17.1 Qiagen (Germany) Basic Information
            9.17.2 Qiagen (Germany) Gene Knockdown Product Overview
            9.17.3 Qiagen (Germany) Gene Knockdown Product Market Performance
            9.17.4 Qiagen (Germany) Business Overview
            9.17.5 Qiagen (Germany) Recent Developments
  10 Gene Knockdown Market Forecast by Region
      10.1 Global Gene Knockdown Market Size Forecast
      10.2 Global Gene Knockdown Market Forecast by Region
            10.2.1 North America Market Size Forecast by Country
            10.2.2 Europe Gene Knockdown Market Size Forecast by Country
            10.2.3 Asia Pacific Gene Knockdown Market Size Forecast by Region
            10.2.4 South America Gene Knockdown Market Size Forecast by Country
            10.2.5 Middle East and Africa Forecasted Sales of Gene Knockdown by Country
  11 Forecast Market by Type and by Application (2026-2033)
      11.1 Global Gene Knockdown Market Forecast by Type (2026-2033)
      11.2 Global Gene Knockdown Market Forecast by Application (2026-2033)
  12 Conclusion and Key Findings
Santa Cruz Biotechnology (US)
OriGene (US)
Sigma-Aldrich (US)
Abnova (Taiwan)
Agilent Technologies (US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals (US)
EMD Millipore (US)
BioVision (US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen (US)
Qiagen (Germany)
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400